Motley Fool Asset Management LLC Exact Sciences Corp Transaction History

Motley Fool Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$56.27 - $73.77 $470,923 - $617,381	8,369 Added 285.53%	11,300 $780,000
Q4 2023 Feb 02, 2024	SELL	$59.06 - $75.72 $18,308 - $23,473	-310 Reduced 9.56%	2,931 $216,000
Q3 2023 Nov 13, 2023	SELL	$65.94 - $99.04 $2,505 - $3,763	-38 Reduced 1.16%	3,241 $221,000
Q2 2023 Aug 09, 2023	BUY	$62.68 - $95.05 $205,527 - $311,668	3,279 New	3,279 $307,000
Q2 2022 Aug 11, 2022	SELL	$35.61 - $76.23 $133,786 - $286,396	-3,757 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$57.56 - $82.54 $210,612 - $302,013	3,659 Added 3733.67%	3,757 $263,000
Q4 2021 Feb 10, 2022	BUY	$72.5 - $100.68 $7,105 - $9,866	98 New	98 $8,000

637

166M

1.93M

1.23M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Motley Fool Asset Management LLC with notifications on news.